A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone - Concepedia

Concepedia

Publication | Open Access

A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone

DOI Full Paper Access

117

Citations

33

References

2020

Year

Julie N. Graff, Tomasz M. Beer, Joshi J. Alumkal, Rachel Slottke, William L. Redmond, George Thomas, Reid F. Thompson, Mary A. Wood, Yoshinobu Koguchi, Yiyi Chen,

Journal for ImmunoTherapy of Cancer

Abstract

clinicaltrials.gov (NCT02312557).

References

	Year	Citations

Page 1